2689 Stock Overview
Provides various solutions to medical institutions, research laboratories of universities and companies, nursing care facilities, and individuals in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
OLBA HEALTHCARE HOLDINGS, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,024.00 |
| 52 Week High | JP¥2,234.00 |
| 52 Week Low | JP¥1,619.00 |
| Beta | 0 |
| 11 Month Change | 4.65% |
| 3 Month Change | 7.95% |
| 1 Year Change | 14.03% |
| 33 Year Change | 28.75% |
| 5 Year Change | 44.57% |
| Change since IPO | 462.22% |
Recent News & Updates
Shareholder Returns
| 2689 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0.5% | -1.3% | -0.4% |
| 1Y | 14.0% | -6.5% | 11.4% |
Return vs Industry: 2689 exceeded the JP Healthcare industry which returned -6.5% over the past year.
Return vs Market: 2689 exceeded the JP Market which returned 11.4% over the past year.
Price Volatility
| 2689 volatility | |
|---|---|
| 2689 Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2689 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2689's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | 1,354 | Yohei Maeshima | www.olba.co.jp |
OLBA HEALTHCARE HOLDINGS, Inc., together with its subsidiaries, provides various solutions to medical institutions, research laboratories of universities and companies, nursing care facilities, and individuals in Japan. The company operates through three segments: Medical Equipment Business, Supply Processing & Distribution Business, and Nursing Care Products Business. The Medical Equipment Business segment engages in the wholesale of medical equipment comprising artificial joints, coronary stents, steel instruments, osteosynthesis materials made of metal and ceramics, ultrasonic scalpels, and pacemakers and catheters related to examination, diagnosis, and treatment of the heart and blood vessels; X-ray fluoroscopy and CT equipment for tumor and embolism treatment, and endoscopes for cancer treatment; and diagnostic imaging equipment, such as MRI and CT to ventilators, and intraoperative monitors, as well as operating room equipment, including shadowless lights.
OLBA HEALTHCARE HOLDINGS, Inc. Fundamentals Summary
| 2689 fundamental statistics | |
|---|---|
| Market cap | JP¥12.05b |
| Earnings (TTM) | JP¥1.50b |
| Revenue (TTM) | JP¥120.11b |
8.0x
P/E Ratio0.1x
P/S RatioIs 2689 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2689 income statement (TTM) | |
|---|---|
| Revenue | JP¥120.11b |
| Cost of Revenue | JP¥106.30b |
| Gross Profit | JP¥13.81b |
| Other Expenses | JP¥12.31b |
| Earnings | JP¥1.50b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 253.62 |
| Gross Margin | 11.50% |
| Net Profit Margin | 1.25% |
| Debt/Equity Ratio | 27.2% |
How did 2689 perform over the long term?
See historical performance and comparison